
Sign up to save your podcasts
Or
In this episode, Dr. Kate O’Brien, Director of the Department of Immunization, Vaccines, and Biologicals at the World Health Organization (WHO) shares her perspective on the state of global immunization programs halfway through Immunization Agenda 2030; the challenges associated with current measles outbreaks in the United States and around the world; why people who have never seen children die from preventable diseases may seem complacent about vaccines; steps that can be taken to strengthen vaccine confidence while ensuring equitable access to immunization programs; and what’s at risk as the United States and other funders cut support for biomedical research and development at a moment when there are numerous promising products to prevent infectious diseases in the research and development pipeline.
4.4
5454 ratings
In this episode, Dr. Kate O’Brien, Director of the Department of Immunization, Vaccines, and Biologicals at the World Health Organization (WHO) shares her perspective on the state of global immunization programs halfway through Immunization Agenda 2030; the challenges associated with current measles outbreaks in the United States and around the world; why people who have never seen children die from preventable diseases may seem complacent about vaccines; steps that can be taken to strengthen vaccine confidence while ensuring equitable access to immunization programs; and what’s at risk as the United States and other funders cut support for biomedical research and development at a moment when there are numerous promising products to prevent infectious diseases in the research and development pipeline.
1,219 Listeners
3,877 Listeners
8,493 Listeners
277 Listeners
3,905 Listeners
6,287 Listeners
6,646 Listeners
1,518 Listeners
141 Listeners
3 Listeners
701 Listeners
27 Listeners
2,245 Listeners
149 Listeners
86 Listeners
6 Listeners
93 Listeners
875 Listeners
17 Listeners
616 Listeners
1 Listeners
13 Listeners
129 Listeners
6 Listeners
2 Listeners
15,313 Listeners
25 Listeners
4 Listeners
2 Listeners
7 Listeners
5 Listeners
5 Listeners
31 Listeners